Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Spatially Resolved Transcriptomics Unveils Unique T-Cell Dysfunctional States and Prognostic Gene Expression Signatures in TP53 -Mutated Acute Myeloid Leukemia

Jayakumar Vadakekolathu, Heidi Altmann, Manja Wobus, Malte von Bonin, Marc Schmitz, Gustavo B. Baretton, Robert Zeiser, Martin Bornhäuser, Sergio Rutella

Blood (2023) 142 (Supplement 1): 291.

https://doi.org/10.1182/blood-2023-174871

Published: 2023

Journal Articles

Targeting intracellular WT1 in AML with a novel RMF-peptide-MHC-specific T-cell bispecific antibody

Blood (2021) 138 (25): 2655–2669.

https://doi.org/10.1182/blood.2020010477

Published: 2021

Includes: Supplemental data

Journal Articles

Application of AI-Based Analytical Approaches for Multiplex Immunophenotyping of SF3B1 -Mutant Myelodysplastic Syndrome Subtype

Susann Winter, Jessica A. Timms, Uta Oelschlaegel, Antje Tunger, Claire N. Harrison, Desmond Choy, Marc Schmitz, Uwe Platzbecker, Shahram Kordasti

Blood (2021) 138 (Supplement 1): 1512.

https://doi.org/10.1182/blood-2021-149706

Published: 2021

Journal Articles

Immune Landscapes Predict Chemotherapy Resistance and Anti-Leukemic Activity of Flotetuzumab, an Investigational CD123×CD3 Bispecific Dart® Molecule, in Patients with Relapsed/Refractory Acute Myeloid Leukemia

Blood (2019) 134 (Supplement_1): 460.

https://doi.org/10.1182/blood-2019-121870

Published: 2019

Journal Articles

Targeting Intracellular WT1 in AML Utilizing a T Cell Bispecific Antibody Construct: Augmenting Efficacy through Combination with Lenalidomide

Blood (2019) 134 (Supplement_1): 4450.

https://doi.org/10.1182/blood-2019-130121

Published: 2019

Journal Articles

Targeting the FMS-like Tyrosin Kinase 3 with the Unicar System: Preclinical Comparison of Murine and Humanized Single-Chain Variable Fragment-Based Targeting Modules

Frederick Fasslrinner, MD, Claudia Arndt, PhD, Anja Feldmann, PhD, Stefanie Koristka, PhD, Liliana Raquel Loureiro, PhD, Marc Schmitz, MD, Gundram Jung, MD, Martin Bornhaeuser, MD, Michael Bachmann, MD

Blood (2019) 134 (Supplement_1): 5614.

https://doi.org/10.1182/blood-2019-124279

Published: 2019

Journal Articles

Immune Gene Expression Profiling in Children and Adults with Acute Myeloid Leukemia Identifies Distinct Phenotypic Patterns

Jayakumar Vadakekolathu, PhD, Tasleema Patel, BSc, Stephen Reeder, BSc, Heidi Schaarschmidt, BSc, Marc Schmitz, MD, Martin Bornhäuser, MD, Sarah E. Warren, PhD, Tressa Hood, MS, Patrick Danaher, PhD, Alessandra Cesano, Joseph M. Beechem, PhD, A. Graham Pockley, PhD, Sarah K Tasian, MD, Sergio Rutella, MDPhDFRCPath

Blood (2017) 130 (Supplement 1): 3942.

https://doi.org/10.1182/blood.V130.Suppl_1.3942.3942

Published: 2017

Journal Articles

ROR1 Specific T Cell Clones from Healthy Individuals Show Common T Cell Receptor Motifs

Falk Heidenreich, PhD, Elke Ruecker-Braun, PhD, Juliane S. Stickel, MD, Anne Eugster, PhD, Denise Kühn, BSc, Sevina Dietz, Annika Nelde, Antje Tunger, MSc, Rebekka Wehner, PhD, Jan Moritz Middeke, MD, Cornelia S Link, MD, Friedrich Stölzel, MD, Stefan Stevanovic, PhD, Ezio Bonifacio, PhD, Martin Bornhäuser, MD, Gerhard Ehninger, MD, Marc Schmitz, PhD, Johannes Schetelig, MD MSc

Blood (2016) 128 (22): 3364.

https://doi.org/10.1182/blood.V128.22.3364.3364

Published: 2016

Journal Articles

Evaluation of Various Strategies to Generate NPM1mut-Specific T Cell Clones

Elke Ruecker-Braun, PhD, Falk Heidenreich, PhD, Cornelia S Link, MD, Maria Schmiedgen, BSc, Rebekka Wehner, PhD, Denise Kühn, BSc, Katharina Heidrich, MD, Nael Alakel, MD, Marc Schmitz, PhD, Christian Thiede, MD, Gerhard Ehninger, MD, Martin Bornhäuser, MD, Johannes Schetelig, MD MSc

Blood (2016) 128 (22): 5718.

https://doi.org/10.1182/blood.V128.22.5718.5718

Published: 2016

Journal Articles

Response and Long-Term Outcome After Treatment With Third-Party Mesenchymal Stromal Cells - Updated Results In 58 Patients With Steroid-Refractory Acute Graft-Versus Host Disease -

Felix von Dalowski, Michael Kramer, PhD, Martin Wermke, MD, Christoph Röllig, MD, Nael Alakel, MD, Friedrich Stölzel, MD, Stefani Parmentier, MD, Katja Sockel, MD, Mathias Krech, PhD, Marc Schmitz, MD, Uwe Platzbecker, MD, PhD, Johannes Schetelig, MD, M. Sc, Martin Bornhauser, MD, Malte von Bonin, MD

Blood (2013) 122 (21): 4612.

https://doi.org/10.1182/blood.V122.21.4612.4612

Published: 2013

Journal Articles

Influence Of Steroid Exposure On CMV Specific T Cells Following Allogeneic Stem Cell Transplantation

Cornelia S. Link, MD, Elke Rücker-Braun, PhD, Sebastian Tuve, MD, Sarah Matko, Marc Schmitz, MD, Rebekka Wehner, PhD, Antje Tunger, Katja Sockel, MD, Stefani Parmentier, MD, Jan Moritz Middeke, MD, Änne Boldt, MD, Johannes Schetelig, MD, M. Sc,, Markus Odendahl, PhD, Torsten Tonn, MD, Martin Bornhäuser, MD, Falk Heidenreich, PhD

Blood (2013) 122 (21): 5488.

https://doi.org/10.1182/blood.V122.21.5488.5488

Published: 2013

Journal Articles

Screening For Anti-Leukemic CTLs After Allogeneic Hematopoietic Stem Cell Transplantation Applying Streptamer Technology

Falk Heidenreich, PhD, Elke Rücker-Braun, PhD, Sebastian Tuve, MD, Marc Schmitz, MD, Rebekka Wehner, PhD, Antje Tunger, Marcus Odendahl, PhD, Tonn Torsten, MD, Martin Bornhäuser, MD, Johannes Schetelig, MD, M. Sc, Cornelia S. Link, MD

Blood (2013) 122 (21): 5493.

https://doi.org/10.1182/blood.V122.21.5493.5493

Published: 2013

Journal Articles

FcγRIII (CD16) equips immature 6-sulfo LacNAc–expressing dendritic cells (slanDCs) with a unique capacity to handle IgG-complexed antigens

Thomas Döbel, Anja Kunze, Jana Babatz, Katja Tränkner, Andreas Ludwig, Marc Schmitz, Alexander Enk, Knut Schäkel

Blood (2013) 121 (18): 3609–3618.

https://doi.org/10.1182/blood-2012-08-447045

Published: 2013

Includes: Supplemental data

Journal Articles

Reconstitution of IL-17-Producing T Helper Cells After Allogeneic Hematopoietic Cell Transplantation

Sebastian Tuve, MD, Felix Bahr, Rebekka Wehner, PhD, Uwe Platzbecker, MD, Martin Wermke, MD, Nona Shayegi, MD, Jan Moritz Middeke, MD, Christoph Röllig, Johannes Schetelig, Gerhard Ehninger, Marc Schmitz, MD, Martin Bornhäuser, MD

Blood (2012) 120 (21): 4167.

https://doi.org/10.1182/blood.V120.21.4167.4167

Published: 2012

Journal Articles

Azacytidine Compromises NK-Cell Activity in AML and MDS Patients Undergoing MRD-Based Pre-Emptive Treatment After Allogeneic Stem Cell Transplantation

Katja Sockel, MD, Claudia Schönefeldt, MSc, Sieghart Sopper, Martin Wermke, MD, Marc Schmitz, MD, Gerhard Ehninger, Martin Bornhäuser, MD, Dominik Wolf, MD, Uwe Platzbecker, MD

Blood (2012) 120 (21): 4122.

https://doi.org/10.1182/blood.V120.21.4122.4122

Published: 2012

Journal Articles

Chimeric Antigen Receptor-Engineered T Cells for Immunotherapy of Acute Myeloid Leukemia

Marc Cartellieri, Irene Michalk, Malte von Bonin, Thomas Krüger, Slava Stamova, Stefanie Koristka, Claudia Arndt, Anja Feldmann, Marc Schmitz, Martin Wermke, MD, Dirk Lindemann, Martin Bornhäuser, Gerhard Ehninger, MD, Michael Bachmann

Blood (2011) 118 (21): 2618.

https://doi.org/10.1182/blood.V118.21.2618.2618

Published: 2011

Journal Articles

Antigen-Specific Redirection of Human Regulatory T Cells by Bispecific Antibodies,

Stefanie Koristka, Marc Cartellieri, Anke Theil, Claudia Arndt, Anja Feldmann, Irene Michalk, Marc Schmitz, Karsten Kretschmer, Martin Bornhäuser, MD, Gerhard Ehninger, MD, Michael Bachmann

Blood (2011) 118 (21): 4041.

https://doi.org/10.1182/blood.V118.21.4041.4041

Published: 2011

Journal Articles

Prophylactic transfer of BCR-ABL–, PR1-, and WT1-reactive donor T cells after T cell–depleted allogeneic hematopoietic cell transplantation in patients with chronic myeloid leukemia

Martin Bornhäuser, Christian Thiede, Uwe Platzbecker, Alexander Kiani, Uta Oelschlaegel, Jana Babatz, Doris Lehmann, Kristina Hölig, Jörgen Radke, Sebastian Tuve, Martin Wermke, Rebekka Wehner, Hanka Jähnisch, Michael P. Bachmann, E. Peter Rieber, Johannes Schetelig, Gerhard Ehninger, Marc Schmitz

Blood (2011) 117 (26): 7174–7184.

https://doi.org/10.1182/blood-2010-09-308569

Published: 2011

Journal Articles

Appearance of Mature 6-Sulfo LacNAc + Dendritic Cells In Early and Late Engraftment After Allogeneic Stem Cell Transplantation.

Sebastian Tuve, Konrad Mager, Rebekka Wehner, Felix Bahr, Uta Ölschlegel, Nona Shayegi, Jan Moritz Middeke, Conrad Heuchel, Christoph Röllig, Jörgen Radke, Martin Wermke, Uwe Platzbecker, Johannes Schetelig, Christian Thiede, Gerhard Ehninger, Prof., Martin Bornhaeuser, Marc Schmitz

Blood (2010) 116 (21): 3720.

https://doi.org/10.1182/blood.V116.21.3720.3720

Published: 2010

Journal Articles

Differences in Reconstitution of NK-Cell Subsets and Expression of Effector Molecules after HLA-Identical and Haploidentical Allogeneic Stem Cell Transplantation in Patients with AML.

Uwe Platzbecker, MD, Astrid Schulze, Uta Oelschlagel, MD, Holger Schirutschke, Marc Schmitz, MD, Gerhard Ehninger, MD, Martin Bornhauser, MD

Blood (2005) 106 (11): 1411.

https://doi.org/10.1182/blood.V106.11.1411.1411

Published: 2005

NARROW

Spatially Resolved Transcriptomics Unveils Unique T-Cell Dysfunctional States and Prognostic Gene Expression Signatures in TP53 -Mutated Acute Myeloid Leukemia

Targeting intracellular WT1 in AML with a novel RMF-peptide-MHC-specific T-cell bispecific antibody

Application of AI-Based Analytical Approaches for Multiplex Immunophenotyping of SF3B1 -Mutant Myelodysplastic Syndrome Subtype

Immune Landscapes Predict Chemotherapy Resistance and Anti-Leukemic Activity of Flotetuzumab, an Investigational CD123×CD3 Bispecific Dart® Molecule, in Patients with Relapsed/Refractory Acute Myeloid Leukemia

Targeting Intracellular WT1 in AML Utilizing a T Cell Bispecific Antibody Construct: Augmenting Efficacy through Combination with Lenalidomide

Targeting the FMS-like Tyrosin Kinase 3 with the Unicar System: Preclinical Comparison of Murine and Humanized Single-Chain Variable Fragment-Based Targeting Modules

Immune Gene Expression Profiling in Children and Adults with Acute Myeloid Leukemia Identifies Distinct Phenotypic Patterns

ROR1 Specific T Cell Clones from Healthy Individuals Show Common T Cell Receptor Motifs

Evaluation of Various Strategies to Generate NPM1mut-Specific T Cell Clones

Response and Long-Term Outcome After Treatment With Third-Party Mesenchymal Stromal Cells - Updated Results In 58 Patients With Steroid-Refractory Acute Graft-Versus Host Disease -

Influence Of Steroid Exposure On CMV Specific T Cells Following Allogeneic Stem Cell Transplantation

Screening For Anti-Leukemic CTLs After Allogeneic Hematopoietic Stem Cell Transplantation Applying Streptamer Technology

FcγRIII (CD16) equips immature 6-sulfo LacNAc–expressing dendritic cells (slanDCs) with a unique capacity to handle IgG-complexed antigens

Reconstitution of IL-17-Producing T Helper Cells After Allogeneic Hematopoietic Cell Transplantation

Azacytidine Compromises NK-Cell Activity in AML and MDS Patients Undergoing MRD-Based Pre-Emptive Treatment After Allogeneic Stem Cell Transplantation

Chimeric Antigen Receptor-Engineered T Cells for Immunotherapy of Acute Myeloid Leukemia

Antigen-Specific Redirection of Human Regulatory T Cells by Bispecific Antibodies,

Prophylactic transfer of BCR-ABL–, PR1-, and WT1-reactive donor T cells after T cell–depleted allogeneic hematopoietic cell transplantation in patients with chronic myeloid leukemia

Appearance of Mature 6-Sulfo LacNAc + Dendritic Cells In Early and Late Engraftment After Allogeneic Stem Cell Transplantation.

Differences in Reconstitution of NK-Cell Subsets and Expression of Effector Molecules after HLA-Identical and Haploidentical Allogeneic Stem Cell Transplantation in Patients with AML.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only